100 related articles for article (PubMed ID: 26440973)
1. Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.
Kander EM; Raza S; Zhou Z; Gao J; Zakarija A; McMahon BJ; Stein BL
Int J Hematol; 2015 Nov; 102(5):587-93. PubMed ID: 26440973
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
[TBL] [Abstract][Full Text] [Related]
3. A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery.
Andreescu M; Andreescu B
Cureus; 2024 Mar; 16(3):e56008. PubMed ID: 38606222
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'.
Mehta D; Alimam S; McLornan DP; Henry JA; Ahmed S; Ghosh AK; Tyebally S; Walker JM; Patel R; Amerikanou R; O'Nions J; Wilson AJ; Lambert J; Sekhar M; Chen D
Curr Res Transl Med; 2024 Mar; 72(1):103420. PubMed ID: 38262189
[TBL] [Abstract][Full Text] [Related]
5. Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults.
Kucine N
Curr Hematol Malig Rep; 2020 Apr; 15(2):141-148. PubMed ID: 32172359
[TBL] [Abstract][Full Text] [Related]
6. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
Krecak I; Verstovsek S; Lucijanic M
Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
[TBL] [Abstract][Full Text] [Related]
7. Management of polycythaemia vera: a critical review of current data.
McMullin MF; Wilkins BS; Harrison CN
Br J Haematol; 2016 Feb; 172(3):337-49. PubMed ID: 26492433
[TBL] [Abstract][Full Text] [Related]
8. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
Tefferi A
Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
[TBL] [Abstract][Full Text] [Related]
9. The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis.
Samuelson BT; Vesely SK; Chai-Adisaksopha C; Scott BL; Crowther M; Garcia D
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):648-52. PubMed ID: 26569516
[TBL] [Abstract][Full Text] [Related]
10. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
Pietra D; Rumi E; Ferretti VV; Di Buduo CA; Milanesi C; Cavalloni C; Sant'Antonio E; Abbonante V; Moccia F; Casetti IC; Bellini M; Renna MC; Roncoroni E; Fugazza E; Astori C; Boveri E; Rosti V; Barosi G; Balduini A; Cazzola M
Leukemia; 2016 Feb; 30(2):431-8. PubMed ID: 26449662
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
Shanavas M; Popat U; Michaelis LC; Fauble V; McLornan D; Klisovic R; Mascarenhas J; Tamari R; Arcasoy MO; Davies J; Gergis U; Ukaegbu OC; Kamble RT; Storring JM; Majhail NS; Romee R; Verstovsek S; Pagliuca A; Vasu S; Ernst B; Atenafu EG; Hanif A; Champlin R; Hari P; Gupta V
Biol Blood Marrow Transplant; 2016 Mar; 22(3):432-40. PubMed ID: 26493563
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
Čokić VP; Mitrović-Ajtić O; Beleslin-Čokić BB; Marković D; Buač M; Diklić M; Kraguljac-Kurtović N; Damjanović S; Milenković P; Gotić M; Raj PK
Mediators Inflamm; 2015; 2015():453020. PubMed ID: 26491227
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
Verger E; Cassinat B; Chauveau A; Dosquet C; Giraudier S; Schlageter MH; Ianotto JC; Yassin MA; Al-Dewik N; Carillo S; Legouffe E; Ugo V; Chomienne C; Kiladjian JJ
Blood; 2015 Dec; 126(24):2585-91. PubMed ID: 26486786
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.
Martin K
Curr Hematol Malig Rep; 2017 Oct; 12(5):389-396. PubMed ID: 28948496
[TBL] [Abstract][Full Text] [Related]
15. The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.
Kc D; Falchi L; Verstovsek S
Ann Hematol; 2017 Oct; 96(10):1595-1604. PubMed ID: 28808761
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.
Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G
Leukemia; 2018 May; 32(5):1057-1069. PubMed ID: 29515238
[TBL] [Abstract][Full Text] [Related]
17. Acquired von willebrand syndrome in patients with philadelphia-negative myeloproliferative neoplasm.
Song IC; Kang S; Lee MW; Ryu H; Lee HJ; Yun HJ; Jo DY
Blood Res; 2023 Mar; 58(1):42-50. PubMed ID: 36774948
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding.
Huang X; Zhang M; Ai Y; Jiang S; Xiao M; Wang L; Jian Y; Zhuge Y; Zhang C; Chen S
Ther Adv Chronic Dis; 2022; 13():20406223221125691. PubMed ID: 36172080
[TBL] [Abstract][Full Text] [Related]
19. Recurrent and Multiple Intracerebral Hemorrhages in Polycythemia Vera Secondary to Myelofibrosis: A Case Report and Literature Review.
Hasui H; Iseki T; Ueno Y; Kamiyama D; Miyamoto N; Kijima C; Hira K; Komatsu N; Hattori N
Case Rep Neurol; 2022; 14(2):274-280. PubMed ID: 35949202
[TBL] [Abstract][Full Text] [Related]
20. Practical management of the haemorrhagic complications of myeloproliferative neoplasms.
Jones E; Dillon B; Swan D; Thachil J
Br J Haematol; 2022 Nov; 199(3):313-321. PubMed ID: 35724983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
